Ownership history in Engineers Gate Manager LP · 8 quarters on record
This page tracks every 13F SEC filing in which Engineers Gate Manager LP reported a position in RECURSION PHARMACEUTICALS IN (RXRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 10,834 | -83,673 | -88.5% | 0.00% | $53K | $4.88 |
| 2025 Q2 | ADDED | 94,507 | +48,317 | +104.6% | 0.01% | $478K | $5.06 |
| 2024 Q4 | REDUCED | 46,190 | -129,205 | -73.7% | 0.01% | $312K | $6.76 |
| 2024 Q3 | ADDED | 175,395 | +97,604 | +125.5% | 0.02% | $1.2M | $6.59 |
| 2024 Q2 | ADDED | 77,791 | +19,630 | +33.8% | 0.01% | $583K | $7.50 |
| 2024 Q1 | ADDED | 58,161 | +46,790 | +411.5% | 0.02% | $580K | $9.97 |
| 2023 Q4 | REDUCED | 11,371 | -70,749 | -86.2% | 0.00% | $112K | $9.86 |
| 2022 Q1 | INITIATED | 82,120 | — | — | 0.02% | $588K | $7.16 |
As of 2025 Q4 — sorted by position size